Bone Biologics Corporation
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
96.61 | 64.63 | 49.48% | -13.71 | -804.49% |
| P/S |
|
0 | 33.51 | -100% |
|
|
| P/BV |
|
0.2988 | 4.52 | -93.39% |
|
|
| P/FCF |
|
0 | 34.27 | -100% |
|
|
| Ev/Ebitda |
|
0.2289 | -19.11 | -101.2% |
|
|
| Ev/S |
|
0 | 22.47 | -100% |
|
|
| Ev/FCF |
|
0.2259 | 39.86 | -99.43% |
|
|
| E/P |
|
0 | 0.0134 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -14.94 | -100% | 0 | 0% |
| ROE |
|
-307.9 | 6.54 | -4809.25% |
|
|
| ROA |
|
-239.41 | -0.7601 | 31397.56% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -28.35 | -100% |
|
|
| ROCE |
|
-648.8 | 12.21 | -5412.76% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.85 | -100% | -3.77 | -100% |
| Nеt Debt/Ebitda |
|
0.321 | -2.93 | -110.95% |
|
|
| Debt/Ratio |
|
0 | 0.17 | -100% |
|
|
| Debt/Equity |
|
0.2861 | 0.6659 | -57.04% |
|
|
| Debt/Net Income |
|
0 | 0.8956 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5431 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.9211 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.26 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 64.77 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5431 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 100.43 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-119.98 | 49.27 | -343.52% | ||
| Growth impulse Net Income in 5 years |
|
163.2 | -8.2 | -2090.24% | ||
| Growth impulse FCF in 5 years |
|
189.57 | 52.45 | 261.43% | ||
| Growth impulse EPS in 5 years |
|
-3.47 | 5.84 | -159.42% |
IP Score
3.88/10
